Fabiana Perna - Search Results

Year	Number of Results
2006	1
2008	2
2010	5
2011	7
2012	3
2013	2
2014	1
2015	4
2016	3
2017	3
2018	2
2019	2
2020	1
2021	4
2022	5
2023	1

1

Integrating Proteomics and Transcriptomics for Systematic Combinatorial Chimeric Antigen Receptor Therapy of AML.

Perna F, Berman SH, Soni RK, Mansilla-Soto J, Eyquem J, Hamieh M, Hendrickson RC, Brennan CW, Sadelain M. Perna F, et al. Cancer Cell. 2017 Oct 9;32(4):506-519.e5. doi: 10.1016/j.ccell.2017.09.004. Cancer Cell. 2017. PMID: 29017060 Free PMC article.

2

Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.

Moran-Crusio K, Reavie L, Shih A, Abdel-Wahab O, Ndiaye-Lobry D, Lobry C, Figueroa ME, Vasanthakumar A, Patel J, Zhao X, Perna F, Pandey S, Madzo J, Song C, Dai Q, He C, Ibrahim S, Beran M, Zavadil J, Nimer SD, Melnick A, Godley LA, Aifantis I, Levine RL. Moran-Crusio K, et al. Among authors: perna f. Cancer Cell. 2011 Jul 12;20(1):11-24. doi: 10.1016/j.ccr.2011.06.001. Epub 2011 Jun 30. Cancer Cell. 2011. PMID: 21723200 Free PMC article.

3

Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy.

Themeli M, Kloss CC, Ciriello G, Fedorov VD, Perna F, Gonen M, Sadelain M. Themeli M, et al. Among authors: perna f. Nat Biotechnol. 2013 Oct;31(10):928-33. doi: 10.1038/nbt.2678. Epub 2013 Aug 11. Nat Biotechnol. 2013. PMID: 23934177 Free PMC article.

4

Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells.

Zhao Z, Condomines M, van der Stegen SJC, Perna F, Kloss CC, Gunset G, Plotkin J, Sadelain M. Zhao Z, et al. Among authors: perna f. Cancer Cell. 2015 Oct 12;28(4):415-428. doi: 10.1016/j.ccell.2015.09.004. Cancer Cell. 2015. PMID: 26461090 Free PMC article.

5

Safety Starts with Selecting the Targets.

Perna F. Perna F. Mol Ther. 2021 Feb 3;29(2):424-425. doi: 10.1016/j.ymthe.2021.01.011. Epub 2021 Jan 12. Mol Ther. 2021. PMID: 33472030 Free PMC article. Review. No abstract available.

6

Novel Immune-Based treatments for Diffuse Large B-Cell Lymphoma: The Post-CAR T Cell Era.

Atallah-Yunes SA, Robertson MJ, Davé UP, Ghione P, Perna F. Atallah-Yunes SA, et al. Among authors: perna f. Front Immunol. 2022 Jun 1;13:901365. doi: 10.3389/fimmu.2022.901365. eCollection 2022. Front Immunol. 2022. PMID: 35720352 Free PMC article. Review.

7

Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemia.

Schorr C, Perna F. Schorr C, et al. Among authors: perna f. Front Immunol. 2022 Dec 20;13:1085978. doi: 10.3389/fimmu.2022.1085978. eCollection 2022. Front Immunol. 2022. PMID: 36605213 Free PMC article. Review.

8

Immune-Based Therapeutic Interventions for Acute Myeloid Leukemia.

Perna F, Espinoza-Gutarra MR, Bombaci G, Farag SS, Schwartz JE. Perna F, et al. Cancer Treat Res. 2022;183:225-254. doi: 10.1007/978-3-030-96376-7_8. Cancer Treat Res. 2022. PMID: 35551662

9

Beyond transcription factors: how oncogenic signalling reshapes the epigenetic landscape.

Liu F, Wang L, Perna F, Nimer SD. Liu F, et al. Among authors: perna f. Nat Rev Cancer. 2016 Jun;16(6):359-72. doi: 10.1038/nrc.2016.41. Nat Rev Cancer. 2016. PMID: 27220480 Free PMC article. Review.

10

Topical Steroids and Glaucoma Filtration Surgery Outcomes: An In Vivo Confocal Study of the Conjunctiva.

Mastropasqua L, Brescia L, D'Arcangelo F, Nubile M, D'Onofrio G, Totta M, Perna F, Aloia R, Agnifili L. Mastropasqua L, et al. Among authors: perna f. J Clin Med. 2022 Jul 7;11(14):3959. doi: 10.3390/jcm11143959. J Clin Med. 2022. PMID: 35887722 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results